Twin drug setbacks pile pressure on Novartis pipeline, CEO

Setback increases pressure on CEO Vas Narasimhan and his mergers-and-acquisitions strategy.

Twin drug setbacks pile pressure on Novartis pipeline, CEO
Setback increases pressure on CEO Vas Narasimhan and his mergers-and-acquisitions strategy.